Ventana Medical Systems Overview
- Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
952
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
2
Ventana Medical Systems General Information
Description
Provider of slide staining systems used to automate the processing and microscopic analysis of human tissue for the detection and treatment of cancer and infectious diseases. The company also sells consumables such as reagents and slides needed to operate the systems. The company provides iScan HT slide scanners for anatomic pathology laboratories and INFORM HER2 Dual ISH DNA Probe cocktail assay for determination of HER2 gene status in breast cancer, as well as used as an aid in the assessment of patients considered for treatment with Herceptin.
Contact Information
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Surgical Devices
Drug Delivery
Parent Company
Primary Office
- East Innovation Park Drive
- Oro Valley, AZ 85737
- United States
+1 (520) 000-0000
Ventana Medical Systems Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ventana Medical Systems Patents
Ventana Medical Systems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210383091-A1 | Method of storing and retrieving digital pathology analysis results | Pending | 03-Jun-2020 | 0000000000 | |
| US-20210397870-A1 | Systems and methods for computing the contributions of autofluorescence in multichannel image | Pending | 13-Feb-2019 | 000000000 | |
| EP-3924722-A1 | Systems and methods for computing the contributions of autofluorescence in multichannel images | Pending | 13-Feb-2019 | 000000000 | |
| JP-2022520603-A | Systems and methods for calculating the contribution of autofluorescence in multichannel images | Pending | 13-Feb-2019 | 000000000 | |
| US-20210373024-A1 | Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer | Pending | 05-Feb-2019 | G01N33/57419 |
Ventana Medical Systems Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Ventana Medical Systems Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ventana Medical Systems Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 23-Aug-2010 | 0000000000 | 00000 | Diagnostic Equipment | |
| Spring Bioscience | 05-Sep-2007 | Merger/Acquisition | 000.00 | Biotechnology | 000000000 |